Publications by authors named "Yu Tashiro"

Claim this Profile
A
A successful case of urinary rediversion from a complicated cutaneous ureterostomy to a new ileal conduit.
Yu Tashiro, Mami Yamazaki, Yasuaki Katsunaga, Go Takeuchi, Satoshi Nagayama

IJU Case Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity.
Hiroshi Fujiwara, Masashi Kubota, Yu Hidaka, Kaoru Ito, Takashi Kawahara, Yu Tashiro

Int J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of prognostic factors and prostate-specific antigen dynamics in Japanese patients with metastatic hormone-sensitive prostate cancer who received combined androgen blockade therapy with bicalutamide.
Yu Tashiro, Shusuke Akamatsu, Kentaro Ueno, Toshiyuki Kamoto, Naoki Terada

Int J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of renal cell carcinoma with antiphospholipid syndrome treated by robot-assisted partial nephrectomy.
Yu Tashiro, Satoshi Ishitoya, Ryo Yamamoto, Kyohei Sugiyama, Hideaki Takada

IJU Case Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab.
Minoru Kato, Takashi Kobayashi, Yoshiyuki Matsui, Katsuhiro Ito, Kensuke Hikami, Yu Tashiro

Int J Urol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy.
Rihito Aizawa, Kenji Takayama, Kiyonao Nakamura, Takashi Ogata, Takahiro Inoue, Yu Tashiro

Int J Urol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort.
Katsuhiro Ito, Takashi Kobayashi, Takahiro Kojima, Kensuke Hikami, Takeshi Yamada, Yu Tashiro

Cancer Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overactive bladder medication: Persistence, drug switching, and reinitiation.
Takeshi Soda, Yu Tashiro, Shuhei Koike, Ryosuke Ikeuchi, Takuya Okada

Neurourol Urodyn· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis